Catalyst Wire Dossier Catalyst Wire Dossier

IWILFIN

Eflornithine hydrochloride · USWM, LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IWILFIN, covering 2023-12-13 to 2024-11-26. Get the full timeline:

Most recent: FDA Approved: IWILFIN — Supplemental Application (USWM, LLC)

See pricing